
News|Articles|February 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 3, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, February 3, 2022, at 11:30 PM, EDT:
41.9% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, February 3, 2022, at 11:30 PM, EDT:
• 64% of total US population
• 68% of US population aged ≥5 years
• 72.6% of US population aged ≥12 years
• 74.2% of US population aged ≥18 years
• 88.4% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 79.7%
2. Vermont: 79.5%
3. Rhode Island: 79.2%
4. Maine: 77.6%
5. Connecticut: 76.7%
2. Vermont: 79.5%
3. Rhode Island: 79.2%
4. Maine: 77.6%
5. Connecticut: 76.7%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, February 3, 2022 at 3:20 PM, EDT, there have been:
• 75 907 127 confirmed cases and
• 896 238 deaths
• 896 238 deaths
The 5 states with the highest total confirmed cases are:
1. California: 8 553 557
2. Texas: 6 358 807
3. Florida: 5 572 757
4. New York: 4 831 404
5. Illinois: 2 939 099
2. Texas: 6 358 807
3. Florida: 5 572 757
4. New York: 4 831 404
5. Illinois: 2 939 099
Deaths: California has the highest number of deaths due to COVID-19 with 80 588 reported fatalities, followed by Texas with 80 290 and Florida with 65 273.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 387 019 718 confirmed cases, 5 707 382 deaths, and 10 007 895 213 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
2
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
3
Age, Not Menopause Stage, Drives Cortical Volume Reduction in Midlife Women, New Study Suggests
4
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
5